http://dermatologytimes.modernmedicine.com/dermatologytimes The Leading Newsmagazine for Dermatologists. Dermatology Times is a newsmagazine devoted to reporting timely information on the latest trends in the dermatology market. As such, it covers new procedures; advances in therapy, new products and drugs, the latest information presented at meetings, interviews with leaders in practice, academics and research. 2008-11-21T00:11:34Z http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/FDA-panel-says-filler-product-labels-should-be-str/ArticleStandard/Article/detail/567160?ref=25 Washington — An FDA panel has decided that product labels on wrinkle fillers should be strengthened to include long-term effects, such as possible scarring, the Wall Street Journal reports. 2008-11-19T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472008/567160null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Indigo-naturalis-may-effectively-treat-psoriasis/ArticleStandard/Article/detail/566748?ref=25 Hong Kong — Indigo naturalis, a plant used in traditional Chinese medicine, may be effective in treating psoriasis, according to a study. 2008-11-18T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/472008/566748null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Valeant-Pharmaceuticals-acquires-DermaTech/ArticleStandard/Article/detail/566079?ref=25 Aliso Viejo, Calif. — Valeant Pharmaceuticals has announced it has acquired DermaTech, an Australian pharmaceutical company focused on dermatology products, marketwatch reports. 2008-11-14T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/462008/566079null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Dr-Zoe-Diana-Draelos-joins-Histogenrsquos-scientif/ArticleStandard/Article/detail/565885?ref=25 San Diego — Histogen has announced that Zoe Diana Draelos, M.D., will be joining the company’s scientific advisory board, PR Newswire reports. 2008-11-13T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/462008/565885null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Scientists-discover-way-to-potentially-restore-col/ArticleStandard/Article/detail/565871?ref=25 World report — Scientists may have discovered a way to restore color to white hair following illness, according to a study published in the British Journal of Dermatology. 2008-11-13T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/462008/565871null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Study-compares-capryloyl-salicylic-acid-and-glycol/ArticleStandard/Article/detail/565674?ref=25 Clark, N.J. — A recent L’oréal research study compared the efficacy of glycolic acid (GA) to capryloyl salicylic acid (LHA)in treating wrinkles hyperpigmentation, inside cosmeceuticals reports. 2008-11-12T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/462008/565674null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Web+Exclusive/Global-leader-Canadian-derm-to-head-World-Medical-/ArticleStandard/Article/detail/564895?ref=25 Toronto — Canadian dermatologist Dana W. Hanson, M.D., has been elected the 2009-10 president of the World Medical Association (WMA), a France-based independent confederation of 94 national medical associations representing more than 8 million doctors worldwide. 2008-11-10T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/462008/564895/world_thumbnail.jpg http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/462008/564895null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/New-study-shows-efficacy-of-astaxanthin/ArticleStandard/Article/detail/564798?ref=25 National report — New research suggests astaxanthin is superior to other carotenoids in sun protection, NPI center reports. 2008-11-10T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/462008/564798null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Skinvisible-appoints-new-international-advisory-bo/ArticleStandard/Article/detail/564793?ref=25 Las Vegas — Skinvisible has announced the appointment of Geert Cauwenbergh, Ph.D., as the head of its International Advisory Board, MarketWatch reports. 2008-11-10T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/462008/564793null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Isolagen-Therapy-effective/ArticleStandard/Article/detail/562717?ref=25 Exton, Pa. — Isolagen has presented an analysis of phase 3 study data of Isolagen Therapy for the treatment of nasolabial folds, PR Newswire reports. 2008-11-04T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562717null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/T-cell-infusion-therapy/ArticleStandard/Article/detail/562719?ref=25 France — Melanoma patients treated with a special tumor-fighting T cell have a greater change of survival without relapse, according to HealthDay News. 2008-11-04T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562719null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Single-laser-best-option/ArticleStandard/Article/detail/562720?ref=25 Tehran, Iran — Though the long-pulsed Nd:YAG laser and the alexandrite laser are both efficacious in long-term hair removal, a combination of the two lasers causes more adverse effects with no additional benefit, HealthDay News reports. 2008-11-04T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562720null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Post-marketing-ArteFill-study/ArticleStandard/Article/detail/562722?ref=25 San Diego — Artes Medical has announced enrollment is completed in the 1,000-patient post-marketing study required by the Food and Drug Administration for ArteFill, the only FDA-approved non-resorbable dermal filler, according to Business Wire. 2008-11-04T05:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562722null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Finance-Trend-setting-In-a-volatile-economy-expert/ArticleStandard/Article/detail/563271?ref=25 As we near the end of 2008 — one of the most economically volatile years in my memory—it seems natural to wonder what the coming year will bring. Even in the most stable of economic times, predicting future developments is an unwise indulgence at best. In times like these, it's pure madness. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563271null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Archiving-images-Cataloging-techniques-are-key-to-/ArticleStandard/Article/detail/563273?ref=25 Photography plays a valuable role in dermatology for improving patient care, but the usefulness of archived images depends on how they are stored. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563273null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Decoding-ACD-Keratinocytes-play-role-in-all-phases/ArticleStandard/Article/detail/563245?ref=25 Allergic contact dermatitis is a cell-mediated condition in which natural killer T cells act both locally in the skin and systemically. Researchers have identified a novel transcription factor that regulates the molecule that natural killer T cells recognize when they migrate into the skin. The finding points to a new pharmacological target in the treatment of allergic contact dermatitis. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563245null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Skin-of-color-Studies-lacking-on-rosacea-in-ethnic/ArticleStandard/Article/detail/563249?ref=25 Although there is a lot of ongoing research into rosacea and a number of FDA-approved medications, very little of either have to do with skin of color. Research protocols have not included ethnic skin, and medications were approved before the FDA required the inclusion of ethnic subjects. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563249/DT11803rosaceaBLACKEYES_rev_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Lower-face-Botox-Universal-Angle-of-Beauty-aids-ae/ArticleStandard/Article/detail/563254?ref=25 A concept called the "Universal Angle of Beauty," which measures the slope from the cheekbones to the chin, can help physicians and patients assess botulinum toxin treatments of the lower face, the concept's creator says. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563254/botox_woman_rev_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/AKs-in-seniors-Study-participants-demonstrate-high/ArticleStandard/Article/detail/563264?ref=25 In a recent study, seniors showed an unexpectedly high rate of compliance with 0.5 percent five-fluorouracil treatment for actinic keratoses, the study's lead author says. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563264null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Physician%27s+Profile/Physicians-profile-Making-connections-Happenstance/ArticleStandard/Article/detail/563274?ref=25 Erin Boh, M.D., Ph.D., professor and chairman of dermatology at Tulane University Health Sciences Center, New Orleans, says her life has been a series of seamless connections — or, as she puts it, happenstance. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563274/DT11709.Boh_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Opinion-Protecting-your-reputation-Respond-to-pati/ArticleStandard/Article/detail/562919?ref=25 Unhappy patients have always existed. Just as many physicians say they get patients through word-of-mouth, unhappy patients can create problems through the same medium. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562919null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Understanding-pathogenesis-Apoptosis-disruption-ma/ArticleStandard/Article/detail/563263?ref=25 New knowledge about the molecular pathogenesis of cutaneous lymphomas provides a basis for several new treatments under development, an expert says. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563263null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Psoriasis+Top+Story/The-obesity-factor-Researchers-study-psoriasis-co-/ArticleStandard/Article/detail/563243?ref=25 Etanercept is effective in treating psoriasis in the pediatric population, a study has found. The research also found that patients in the study had increased levels of C-reactive protein, an inflammatory marker that may be elevated as a result of abdominal obesity. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563243null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Q-amp-A-Cause-and-effect-Derms-question-reported-c/ArticleStandard/Article/detail/563255?ref=25 An article published Aug. 14, 2008, in the online version of the Journal of Investigative Dermatology created quite a stir among the media. This paper, titled "Tumorigenic Effect of Some Commonly Used Moisturizing Creams when Applied Topically to UVB-Pretreated High-Risk Mice" (Yao-Ping Lu et al), drew some dubious conclusions regarding the relationship between moisturizers and skin cancer. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563255null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Safety-net-Doctors-contract-with-patients-to-avoid/ArticleStandard/Article/detail/563269?ref=25 The Internet provides a forum for disgruntled patients, employees or competitors to defame a doctor's reputation. One company helps doctors protect themselves from frivolous lawsuits. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563269null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Striking-gold-for-AKs-Trials-show-ingenol-mebutate/ArticleStandard/Article/detail/563266?ref=25 Ingenol mebutate is taking the dermatology world by storm as it time and again proves its high efficacy and excellent safety profile in the treatment of AKs. Many dermatologists are eagerly awaiting FDA approval of this novel topical therapy in the United States. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563266null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Hand-veins-Specialized-phlebectomy-technique-impro/ArticleStandard/Article/detail/563256?ref=25 A specialized, minimally invasive phlebectomy technique can improve the appearance of hands with prominent veins. Subcutaneous injection of fat into the hand is also a method of camouflaging protruding hand veins. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563256null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Treating-melasma-Copper-bromide-laser-effectively-/ArticleStandard/Article/detail/563262?ref=25 Targeting the melanocytes in the hypermelanosis seen in melasma is a common and effective therapy. Many therapies exist, including topical approaches, lasers and light therapy. A new approach targeting the vasculature, not the melanocytes, using a copper bromide dual 578 nm yellow laser has proven very effective in the treatment of melasma, a recent study shows. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563262null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Editorial-Looking-to-the-future-Unselfishness-volu/ArticleStandard/Article/detail/562916?ref=25 It seems that over the past several decades, there has been an apparent increased level of concern about the lack of work ethic and selfish motivation of next generation, and whether or not the world will survive the laid-back, "me first" attitude that seem all too prevalent in the younger generation today. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562916null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Synergistic-effect-Combining-LED-devices-with-PDL-/ArticleStandard/Article/detail/563248?ref=25 Combining laser and light-based treatments for rosacea have a synergistic effect, and the combination works better than each does separately, an expert says. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563248null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Acne-pathogenesis-Researchers-focus-on-elucidating/ArticleStandard/Article/detail/562923?ref=25 Tissue necrosis factor-alpha (TNF-alpha) is a pivotal cytokine in inflammatory pathways, but its role in acne has not been characterized. Studies under way at the University of Miami Miller School of Medicine aim to elucidate more information with the ultimate goal of identifying potential new therapeutic targets for acne. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562923null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Radiesse-makes-the-grade-Multicenter-study-establi/ArticleStandard/Article/detail/563244?ref=25 A multicenter study enrolling 100 patients investigated the safety of calcium hydroxylapatite microspheres (Radiesse, BioForm) injection for treatment of nasolabial folds. After follow-up to six months, there were no clinically significant adverse reactions, including no cases of keloids, hypertrophic scarring or hypo- or hyperpigmentation. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563244null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Treating-vitiligo-Expanding-list-of-options-advanc/ArticleStandard/Article/detail/563241?ref=25 Vitiligo in patients with skin of color can have devastating psychosocial consequences. A variety of newer therapeutic options are improving management for patients with disease manifestation ranging across the spectrum, from localized to general. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563241null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Help-for-homebodies-New-laser-light-technologies-a/ArticleStandard/Article/detail/563259?ref=25 As new laser technology continues to be introduced to the market, patients keep searching for the newest, latest and greatest device. The current trend seems to be centered on what patients can do themselves, minimizing the amount of time needed in the office. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563259null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Atopic-Dermatitis-amp-Occlusion-Positive-patch-tes/ArticleStandard/Article/detail/563242?ref=25 Occlusion in patients with atopic dermatitis causes increased transepidermal water loss (TEWL) and increased regulation of specific inflammatory cytokines, according to one study. The findings suggest positive patch tests in atopic dermatitis patients may not necessarily indicate true allergy. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563242null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Laser+%26+Light+Technology+in+Dermatology+Top+Story/Nonsurgical-skin-tightening-Field-remains-open-for/ArticleStandard/Article/detail/563257?ref=25 Nonsurgical skin-tightening procedures based on deep-tissue energy delivery have many attractive features for consumers and physicians. The number of devices available is expanding, but despite the growth in this industry, results remain variable and modest. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563257null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Direct-talks-How-do-derms-view-DTC-advertising/ArticleStandard/Article/detail/563276?ref=25 National report — According to a recently released study, the $5 billion a year that pharmaceutical companies spend on direct-to-consumer (DTC) advertising may not always be such a good investment. And to some dermatologists, DTC drug advertising may not always be such a good idea from a medical standpoint. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563276null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Skin-Sense-Award-Gala-Foundation-raises-900000-at-/ArticleStandard/Article/detail/563278?ref=25 New York — The Skin Cancer Foundation raised almost $900,000 during its annual Skin Sense Award Gala, an event honoring those who have contributed to educating the public about the prevention, detection and treatment of skin cancer, according to a press release. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563278null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Ear-wedges-Maintaining-understanding-tissue-orient/ArticleStandard/Article/detail/563261?ref=25 When processing an ear wedge during Mohs surgery, maintaining and understanding orientation of the tissue are key, an expert says. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563261null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Photodynamic-therapy-MAL-PDT-improves-inflammatory/ArticleStandard/Article/detail/562921?ref=25 Photodynamic therapy with methyl aminolevulinate cream and red light is associated with marked and relatively durable reductions in inflammatory lesion counts in patients with moderate inflammatory acne, an expert says. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562921/male_acne_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/3-D-technology-State-of-the-art-imaging-system-inc/ArticleStandard/Article/detail/562922?ref=25 The state-of-the-art 3-D imaging system known as Lifeviz raises the bar in the management of acne and rosacea lesions by allowing the clinician to visualize much more accurately lesion images and, therefore, better follow the treatment progress of patients. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562922null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Relief-for-itching-Dihydroavenanthramide-D-eases-p/ArticleStandard/Article/detail/563246?ref=25 Several ingredients found in topical preparations help treat dry skin and the subsequent symptom of pruritus. The results of a recent study with dihydroavenanthramide D demonstrate the agent is very effective in the treatment of pruritus, and according to one expert, should be considered an option when trying to treat and subdue pruritic symptoms. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563246null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Looking-at-the-links-SID-initiative-to-probe-conne/ArticleStandard/Article/detail/563277?ref=25 Washington — The Society for Investigative Dermatology (SID) launched its multi-year initiative on the Burden of Skin Disease Co-Morbidities at an invitational scientific conference Oct. 15-16 in Bethesda, Md. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563277null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Infliximab-efficacy-expands-TNF-alpha-inhibitors-e/ArticleStandard/Article/detail/563247?ref=25 Some research has demonstrated efficacy with the off-label use of tumor necrosis factor-alpha in treating inflammatory skin conditions such as pyoderma gangrenosum and hidradenitis suppurativa. The use of infliximab, in particular, has resulted in disease quiescence in patients who had either condition, and its use has demonstrated a steroid-sparing effect in patients with pyoderma gangrenosum. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563247null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Growing-threat-MRSA-emergence-poses-infection-prob/ArticleStandard/Article/detail/563320?ref=25 Available data indicates that the number of MRSA infections is increasing in both AD patients and the general population, an expert says. Understanding innate immunity and antimicrobial peptide production may lead to new treatment modalities. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563320null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Now-on-trial-New-rosacea-medications-hold-promise-/ArticleStandard/Article/detail/563251?ref=25 Several new compounds are currently being tested for safety and efficacy in treating rosacea. These medications may make treatment easier for patients, an expert says. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563251null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Protecting-your-assets-All-plans-are-not-created-e/ArticleStandard/Article/detail/563272?ref=25 Too many physicians over the last decade have sought cookie-cutter asset protection plans to give them some "peace of mind" that if they ever endure an outrageous malpractice case, they won't lose everything. While we admire these doctors' commitment to pro-actively managing their risk, we have to remind doctors that all "asset protection plans" are not created equal. In fact, many will not even "work" if they ever are relied on. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563272null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Special-considerations-Exacerbating-factors-mandat/ArticleStandard/Article/detail/562925?ref=25 Topical retinoid treatment is the mainstay of acne management in ethnic skin, as it is in fairer individuals. However, additional considerations are needed to address the unique postinflammatory sequelæ in dark skin and precipitating factors for acne eruptions. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562925null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/New-developments-in-acne-treatment-Novel-topical-o/ArticleStandard/Article/detail/562924?ref=25 Dapsone gel, Oracea capsules and modified photodynamic therapy are three brand-new approaches to acne therapy, all of which may change current acne treatment and management. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562924null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Natural-niche-Cosmeceuticals-play-role-in-rosacea-/ArticleStandard/Article/detail/563250?ref=25 Cosmeceuticals such as Kinerase (Valeant), niacinamide and a combination of methylsulfonylmethane and silymarin can have a place in treating rosacea, particularly when there is a reason why pharmacological therapies can be used. However, as the number of treatments claiming to help with skin redness grows, physicians shouldwarn patients that just because something can treat redness, that doesn't necessarily mean it can treat rosacea. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563250null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Cutaneous-events-Monitoring-needed-with-kinase-inh/ArticleStandard/Article/detail/563265?ref=25 Early recognition and treatment of cutaneous events should be a crucial part of the medical management of patients taking kinase inhibitors, a co-author of a recent case report says. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563265null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Afro-textured-hair-Styling-chemical-use-increase-r/ArticleStandard/Article/detail/563258?ref=25 Women with afro-textured hair are at increased risk of hair breakage and hair loss due to endogenous and exogenous factors. Conditions such as central centrifugal cicatricial alopecia, discoid lupus erythematosus and androgenetic alopecia affect women with afro- textured hair. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563258null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Legislative-Capitol-ideas-Derms-lobby-Congress-dis/ArticleStandard/Article/detail/562918?ref=25 Early in September, a group of dermatologists descended on Capitol Hill, where they met with members of Congress to discuss their concerns and priorities and sought to increase awareness among lawmakers of the importance of dermatology to their constituents. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562918null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Photopneumatic-therapy-Vacuum-assisted-pulsed-ligh/ArticleStandard/Article/detail/562920?ref=25 Patients with acne that is unresponsive to traditional therapies were enrolled in a multicenter study evaluating photopneumatic therapy with a vacuum-assisted pulsed light device (Isolaz, æsthera). The treatment was easy to deliver and well-tolerated. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562920null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Better-barrier-Tetrix-cream-protects-against-irrit/ArticleStandard/Article/detail/563240?ref=25 Several studies show that a new barrier cream provides effective protection against irritants and allergens, its manufacturer says. The cream also withstands gentle hand washing better than a comparator product, a researcher adds. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563240null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Treating-BCC-Imiquimod-therapy-sustains-clearance-/ArticleStandard/Article/detail/563267?ref=25 Several therapies are available for the treatment of superficial basal cell carcinoma (BCC), including excision, PDT, 5-fluorouracil and imiquimod; however, not all of them have the same safety and efficacy profile. A recent study proves that imiquimod is safe and effective for the treatment of superficial BCC and assures sustained clearance over at least five years. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563267null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Postoperative-complications-Academic-audit-identif/ArticleStandard/Article/detail/563260?ref=25 An audit conducted at a university dermatology department suggests that certain factors appear to increase patients' risk of postoperative complications, one of the audit's authors says. However, antibiotic use may reduce such complications, he adds. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563260null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Delving-deeper-Rosacea-peptide-research-focuses-on/ArticleStandard/Article/detail/563252?ref=25 Cathelicidins appear to have dual roles in the skin, working not just as antimicrobials that act as natural antibiotics but also as proponents of healing. Researchers are looking into the underlying workings of antimicrobial cathelicidins with the hope of better understanding their role in osacea. Factors such as toll-like receptors and vitamin D3 appear to be part of the equation. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563252null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Great-greetings-Master-keys-to-making-a-good-first/ArticleStandard/Article/detail/563270?ref=25 First impressions have a strong influence on our perceptions and, ultimately, our loyalty to a service, a company or a physician. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563270null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Verrucous-carcinoma-Case-shows-verrucous-carcinoma/ArticleStandard/Article/detail/563268?ref=25 Because verrucous carcinoma and ILVEN can have striking histologic similarities, one expert recommends considering verrucous carcinoma in the differential diagnosis of ILVEN. Initial biopsies can be misleading, evidence from this case demonstrates. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563268null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Off-site-rosacea-Presentation-on-scalp-back-chest-/ArticleStandard/Article/detail/563253?ref=25 A classic 1-2-3 approach to treating rosacea of the body and scalp is effective, an expert says. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563253null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Getting-sensitive-Repeated-use-of-topical-therapie/ArticleStandard/Article/detail/563817?ref=25 Repeated use of topical therapies for atopic dermatitis may lead to sensitization that results in allergic contact dermatitis. In a recent study, investigators identified several risk factors that are significantly linked with sensitization to local atopic dermatitis therapies. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563817null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Legal-Firing-your-diabetic-employee-Can-you-be-sue/ArticleStandard/Article/detail/562917?ref=25 Dr. Job is a hard-working dermatologist practicing in a city hard hit by the downturn in the economy. Overhead is up, and revenues are down. He is left with no choice but to start terminating some employees. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/562917null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Bridging-the-gap-Connection-communication-can-ease/ArticleStandard/Article/detail/563275?ref=25 National report — With four generations of dermatologists rubbing elbows in medical schools and residency programs, and three generations working side by side in practice and other settings, it's no wonder that doctors of all ages are feeling frustrated. 2008-11-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/452008/563275null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Dusa-Pharmaceuticals-abandons-Levulan-PDT/ArticleStandard/Article/detail/561390?ref=25 Wilmington, Mass. — Dusa Pharmaceuticals has stopped developing Levulan photo dynamic therapy for acne, after mid-stage trials failed to show statistically significant results. 2008-10-27T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/442008/561390null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Psoriasis-Education-Program-launches-new-Web-site/ArticleStandard/Article/detail/560754?ref=25 Toronto, Canada — In honor of World Psoriasis Day on Oct. 29, the Psoriasis Education Program (PEP) announces its new Web site www.psoriasisinfo.ca, MarketWatch reports. 2008-10-23T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/432008/560754null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Laser-treatment-may-reverse-sun-damaged-skin/ArticleStandard/Article/detail/560605?ref=25 Ann Arbor, Mich. — Photodynamic therapy could improve the appearance of sun damaged skin, according to a University of Michigan study. 2008-10-22T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/432008/560605null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Diagnosing-mycosis-fungoides/ArticleStandard/Article/detail/559807?ref=25 Las Vegas — The most common diagnosis of cutaneous T-cell lymphoma diagnosis in the practice of dermatology is mycosis fungoides (MF), according to Peter W. Heald, M.D., professor of dermatology, Yale School of Medicine, New Haven, Conn., who spoke here at the 27th Annual Fall Clinical Dermatology Conference. 2008-10-20T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/432008/559807null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Practical-pointers-to-guide-your-practice/ArticleStandard/Article/detail/559808?ref=25 Las Vegas — When it comes to office efficiency and patient management, experts’ advice runs the gamut, from choosing patient-friendly palliative care to properly using physician extenders. 2008-10-20T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/432008/559808null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/The-pernicious-nature-of-STDs/ArticleStandard/Article/detail/559809?ref=25 Chicago — From the sexual proclivities of senior citizens to the continuing spread of HIV, the state of sexually transmitted diseases (STDs) worldwide is more dire than casual observers would guess, says one expert. 2008-10-20T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/432008/559809null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Female-alopecia-Diagnosis-and-treatment/ArticleStandard/Article/detail/559803?ref=25 Las Vegas — A meticulous history and scalp examination are key in diagnosing and managing hair loss in women, says Jerry Shapiro, M.D., F.R.C.P.C., department of dermatology, New York University, New York, and department of dermatology and skin science, University of British Columbia, Vancouver, Canada, in a presentation at the Fall Clinical Dermatology Conference here. 2008-10-20T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/432008/559803null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Facial-anatomy-demands-constant-attention/ArticleStandard/Article/detail/559805?ref=25 Las Vegas — To paraphrase English surgeon and anatomist Sir Ashley Paston Cooper, the best surgeon is the one who makes the fewest mistakes. 2008-10-20T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/432008/559805null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Fractionated-lasers-combined-wavelength-treatments/ArticleStandard/Article/detail/559806?ref=25 Las Vegas — Throughout the next five years, fractionated lasers and combined-wavelength treatments will continue to lead growth in the dermatologic laser surgery segment, says a leading dermatologic laser surgeon. 2008-10-20T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/432008/559806null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Melanoma-update/ArticleStandard/Article/detail/559804?ref=25 Las Vegas — One American dies from malignant melanoma every hour, according to Darrell S. Rigel, M.D., M.S., co-director of the 27th Annual Fall Clinical Dermatology Conference, and clinical professor of dermatology, New York University School of Medicine, New York. 2008-10-20T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/432008/559804null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Topical-anesthetics-remain-sore-spot/ArticleStandard/Article/detail/559797?ref=25 Las Vegas — Although topical anesthetics have long been a mainstay for dermatologists, physicians have relatively little clinical data with which to evaluate them, an expert says. 2008-10-19T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559797null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Biologic-data-growing/ArticleStandard/Article/detail/559796?ref=25 Las Vegas — As new biologic drugs navigate through the FDA approval process, the amount of efficacy data — including comparative studies — available to dermatologists is growing, says a leading psoriasis clinician and researcher. 2008-10-19T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559796null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Nonmelanoma-skin-cancers/ArticleStandard/Article/detail/559795?ref=25 Las Vegas — Nonsurgical modalities can provide safe, effective treatment for carefully selected low-risk nonmelanoma skin cancers, an expert says. 2008-10-19T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559795null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Filler-choices-creativity-expanding/ArticleStandard/Article/detail/559798?ref=25 Las Vegas — The availability of a broad range of hyaluronic acid (HA) fillers has allowed dermatologists to employ greater creativity in correcting not only facial lines and wrinkles, but also age-related volume loss, an expert says. 2008-10-19T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559798null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Cosmeceuticals-Thoughts-of-a-skeptic-and-a-hypocri/ArticleStandard/Article/detail/559793?ref=25 Las Vegas — Everyone needs a working knowledge of cosmeceuticals, even if you?re a skeptic, says Hilary E. Baldwin, M.D, vice chair and associate professor of dermatology, department of dermatology, State University of New York, Brooklyn, N.Y., in a presentation here at the Fall Clinical Dermatology Conference. 2008-10-19T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559793null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Using-PDT-in-your-practice/ArticleStandard/Article/detail/559794?ref=25 Las Vegas — "It?s my bias that every practice should be using photodynamic therapy (PDT.) It is so useful," says C. William Hanke, M.D., M.P.H., F.A.C.P.; president, American Academy of Dermatology; visiting professor, dermatology, University of Iowa-Carver College of Medicine, Iowa City, Iowa. 2008-10-19T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559794null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Non-steroidal-therapies-in-atopic-dermatitis/ArticleStandard/Article/detail/559799?ref=25 Las Vegas — "There are problems with corticosteroids," says Alan B. Fleischer, Jr., M.D., professor and chair of dermatology, Wake Forest University School of Medicine, Winston-Salem, N.C. 2008-10-19T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559799null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/New-applications-for-botulinum-toxin/ArticleStandard/Article/detail/559785?ref=25 Las Vegas — As injection techniques and aesthetic applications for Botox (botulinum toxin A, Allergan) expand, knowing the facial anatomy and tempering patient expectations remain critical to success, an expert says. 2008-10-18T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559785null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Treating-pigmentary-disorders/ArticleStandard/Article/detail/559786?ref=25 Las Vegas — Treating tough pigmentary disorders requires combining current therapies while keeping abreast of emerging therapies including new sunscreens, resurfacing procedures and promising monotherapeutic bleaching agents, says an expert. 2008-10-18T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559786null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Fungal-cases-provide-lessons/ArticleStandard/Article/detail/559783?ref=25 Las Vegas — A selection of recent cases offer lessons ranging from potential causes of drug-induced subacute cutaneous lupus erythematosus (DISCLE) to comorbidities associated with seborrheic dermatitis, says a physician familiar the cases. 2008-10-18T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559783null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/New-developments-in-atopic-dermatitis/ArticleStandard/Article/detail/559771?ref=25 Las Vegas — "TIMS (topical immune modulators) are safer than topical steroids if you don?t feed them heavily to monkeys," says Lawrence A. Schachner, M.D., chairman and Harvey Blank Professor of Dermatology, professor of pediatrics, and director, division of pediatric dermatology, Leonard M. Miller School of Medicine, University of Miami, Miami, Fla. 2008-10-18T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559771null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Hormonal-treatment-of-acne/ArticleStandard/Article/detail/559772?ref=25 Las Vegas — When an adult female presents with acne, it can be very helpful to do a hormonal evaluation, including a menstrual history, use of cosmetic and skincare products and clinical signs of cutaneous androgen excess, says Diana S. Berson, M.D., in a presentation here at the Fall Clinical Dermatology Conference. 2008-10-18T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559772null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Advances-in-pediatric-dermatitis/ArticleStandard/Article/detail/559782?ref=25 Las Vegas — Kawasaki disease (KD), also called mucocutaneous lymph node syndrome, is the most common cause of acquired cardiac disease in children, and it is important to understand its pathogenesis in order to diagnose and treat the child, says Sheila Fallon Friedlander, M.D., clinical professor, pediatrics and medicine, University of California San Diego Medical Center, Rady Children?s Hospital, San Diego. 2008-10-18T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559782null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Infectious-diseases-A-never-ending-battle/ArticleStandard/Article/detail/559784?ref=25 Las Vegas — The evolving nature of infectious diseases that attack the skin requires dermatologists to maintain constant vigilance, an expert says. 2008-10-18T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/559784null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Derm-Show-Daily-Images/ArticleStandard/Article/detail/558385?ref=25 2008-10-13T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/422008/558385null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/FDA-postpones-first-cycle-review-of-Dysport/ArticleStandard/Article/detail/556371?ref=25 French pharmaceutical company Ipsen says the U.S. Food and Drug Administration (FDA) will not complete its first-cycle review of Ipsen?s botulinum toxin type A product Dysport until the end of the year, Reuters reports. 2008-10-07T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/402008/556371null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Study-suggest-effectiveness-of-efalizumab-in-treat/ArticleStandard/Article/detail/556381?ref=25 Results of a recent study show that 68 percent of patients with moderate to severe plaque psoriasis experienced improvement in scalp psoriasis within the first 12 weeks of treatment with efalizumab, Docguide.com reports. 2008-10-07T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/402008/556381null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Keraderm-to-introduce-first-phototherapy-treatment/ArticleStandard/Article/detail/556380?ref=25 Keraderm, which develops phototherapy treatments for infections, has announced it will introduce a $100 phototherapy treatment for onychomycosis in 2009, upon completion of current pivotal trials and pending marketing clearance from the Food and Drug Administration (FDA), PRNewswire reports. 2008-10-07T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/402008/556380null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Radiofrequency-device-for-skin-treatment-wins-FDA-/ArticleStandard/Article/detail/556374?ref=25 Syneron Medical Ltd., based here, has received U.S. Food and Drug Administration (FDA) approval for its Matrix RF applicator for use in dermatological procedures requiring skin ablation and resurfacing, CNNMoney.com reports. 2008-10-07T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/402008/556374null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/FDA-says-blood-cancer-drug-linked-to-serious-skin-/ArticleStandard/Article/detail/556376?ref=25 The Food and Drug Administration (FDA) announced that a blood cancer drug may cause a serious skin reaction in some patients, the Dow Jones Newswire reports. 2008-10-07T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/402008/556376null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/JampJ-study-Ustekinumab-superior-to-Enbrel-for-pso/ArticleStandard/Article/detail/556383?ref=25 New Brunswick, N.J. ? A Johnson & Johnson-funded patient study suggests that J&J?s experimental drug ustekinumab was more effective at treating psoriasis than Amgen?s Enbrel, the Wall Street Journal reports. 2008-10-07T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/402008/556383null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Tacrolimus-ointment-effective-for-pediatric-AD-stu/ArticleStandard/Article/detail/556386?ref=25 Data from two large, phase 4 trials indicate that long-term, intermittent, once-daily therapy with tacrolimus ointment is an effective treatment for pediatric patients with stabilized atopic dermatitis, Docguide.com reports. 2008-10-07T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/402008/556386null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/New-research-Botox-betters-first-impressions-three/ArticleStandard/Article/detail/556387?ref=25 New research shows that cosmetic enhancement with Botox (Allergan) positively affects first impressions related to attractiveness, dating success and athleticism, ScienceDaily.com reports. 2008-10-07T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/402008/556387null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Web+Exclusive/lsquoPlay-Safersquo-still-shines-WDS-program-garne/ArticleStandard/Article/detail/556497?ref=25 National report — The news is bright for the Women’s Dermatologic Society’s Play Safe in the Sun campaign. 2008-10-06T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/412008/556497/woman_golfer_thumbnail.jpg http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/412008/556497null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Anika-Therapeutics-announces-Canadian-distribution/ArticleStandard/Article/detail/556289?ref=25 Bedford, Mass. — Anika Therapeutics has signed an agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports. 2008-10-03T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/402008/556289null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Merz-USA-names-new-president-and-CEO/ArticleStandard/Article/detail/556291?ref=25 Greensboro, N.C. — Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to dbusinessnews.com. 2008-10-03T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/402008/556291null HTML